Dynavax Technologies Corp (DVAX)
$1.30
-0.03 (-2.26%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $1.33 |
| Daily Range | $1.30 - $1.36 |
| 52-Week Range | $0.16 - $3.35 |
| Market Cap | $53.66M |
| P/E Ratio | 18.71 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 79,980 |
| Average Daily Volume | 516,000 |
DVAX
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
DVAX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
DVAX News and Commentary
- Lemmings Have Reversed Course Yet Again – Blog at The Motley Fool
- Is The Worst Behind Us? – Blog at The Motley Fool
- Wow Overnight DVAX gets Billion dollar potential Phase III drug back on track – Blog at The Motley Fool
- UPDATE 2-FDA gives Dynavax OK to resume hepatitis B trials – Reuters
- Unloved Stocks Ready to Shine – The Motley Fool
- Dynavax Gets Held Up – The Motley Fool
- Pfizer Finds an Old Friend – The Motley Fool
- Get to Know a Guru – The Motley Fool
Related News and Articles
- Dream Stocks for Biotech Investors – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
RSS Headlines
Fool UK
